Literature DB >> 17992688

(+)-Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal rats.

Curtis E Grace1, Tori L Schaefer, Nicole R Herring, Matthew R Skelton, Anne E McCrea, Charles V Vorhees, Michael T Williams.   

Abstract

(+)-Methamphetamine (MA) administered on postnatal days (P) 11-15 (four times/day) results in increased corticosterone that overlaps the stress hyporesponsive period (SHRP; P2-14) and leads to later learning and memory deficits. Elevated corticosterone during the SHRP results in neurotrophin changes and long-term effects on learning. We determined whether two known stressors could mimic the effects of MA [10 (mg/kg)/dose] administration in neonatal rats. Stressors were four 15-min sessions of forced swim or isolation (confinement in forced swim tubes without water). Saline and weighed-only controls were included and all five treatments were represented within each litter. Corticosterone in plasma and brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in neostriatum and hippocampus were examined after one or four treatments on P11 or P15 (0.5, 1.75, 6.5, or 24 h after first dose). MA increased corticosterone and BDNF; forced swim and isolation also increased corticosterone, but to a lesser extent than MA, and neither stressor increased BDNF. NGF was unaffected by saline treatment, but there was a minor reduction in NGF in the forced swim group compared with the weighed-only group. The data show that MA is more potent at releasing corticosterone and increasing BDNF than short-term, repeated episodes of forced swim or isolation. The possible relationship between these changes and the long-term cognitive effects of developmental MA administration are discussed. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17992688      PMCID: PMC2744944          DOI: 10.1002/syn.20470

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  53 in total

1.  Differential patterns of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 mRNA and protein levels in developing regions of rat brain.

Authors:  K P Das; S L Chao; L D White; W T Haines; G J Harry; H A Tilson; S Barone
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  Euthanasia by decapitation: evidence that this technique produces prompt, painless unconsciousness in laboratory rodents.

Authors:  R R Holson
Journal:  Neurotoxicol Teratol       Date:  1992 Jul-Aug       Impact factor: 3.763

Review 3.  Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period.

Authors:  R M Sapolsky; M J Meaney
Journal:  Brain Res       Date:  1986-03       Impact factor: 3.252

4.  Methamphetamine exposure from postnatal day 11 to 20 causes impairments in both behavioral strategies and spatial learning in adult rats.

Authors:  Michael T Williams; Charles V Vorhees; Francis Boon; Andrea J Saber; Donald P Cain
Journal:  Brain Res       Date:  2002-12-27       Impact factor: 3.252

5.  Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

Authors:  E Gouzoulis-Mayfrank; B Thelen; E Habermeyer; H J Kunert; K A Kovar; H Lindenblatt; L Hermle; M Spitzer; H Sass
Journal:  Psychopharmacology (Berl)       Date:  1999-02       Impact factor: 4.530

6.  Behavioral and growth effects induced by low dose methamphetamine administration during the neonatal period in rats.

Authors:  Michael T Williams; Mary S Moran; Charles V Vorhees
Journal:  Int J Dev Neurosci       Date:  2004 Aug-Oct       Impact factor: 2.457

7.  Early postnatal corticosterone administration regulates neurotrophins and their receptors in septum and hippocampus of the rat.

Authors:  Thomas Roskoden; Uwe Otten; Herbert Schwegler
Journal:  Exp Brain Res       Date:  2003-10-14       Impact factor: 1.972

8.  Methamphetamine abuse during pregnancy and its health impact on neonates born at Siriraj Hospital, Bangkok, Thailand.

Authors:  Chulathida Chomchai; Natawadee Na Manorom; Pornchai Watanarungsan; Panitan Yossuck; Summon Chomchai
Journal:  Southeast Asian J Trop Med Public Health       Date:  2004-03       Impact factor: 0.267

9.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

10.  Methamphetamine exposure during early postnatal development in rats: I. Acoustic startle augmentation and spatial learning deficits.

Authors:  C V Vorhees; K G Ahrens; K D Acuff-Smith; M A Schilling; J E Fisher
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

View more
  20 in total

1.  Long-term effects of early adolescent methamphetamine exposure on depression-like behavior and the hypothalamic vasopressin system in mice.

Authors:  Lauren Joca; Damian G Zuloaga; Jacob Raber; Jessica A Siegel
Journal:  Dev Neurosci       Date:  2014-03-27       Impact factor: 2.984

2.  Effects of adolescent methamphetamine and nicotine exposure on behavioral performance and MAP-2 immunoreactivity in the nucleus accumbens of adolescent mice.

Authors:  Jordan M Buck; Alysse S Morris; Sydney J Weber; Jacob Raber; Jessica A Siegel
Journal:  Behav Brain Res       Date:  2017-01-12       Impact factor: 3.332

3.  Methamphetamine reversed maternal separation-induced decrease in nerve growth factor in the ventral hippocampus.

Authors:  J J Dimatelis; V A Russell; D J Stein; W M Daniels
Journal:  Metab Brain Dis       Date:  2014-01-11       Impact factor: 3.584

4.  Gender, brain-derived neurotrophic factor Val66Met, and frequency of methamphetamine use.

Authors:  Keith G Heinzerling; Steven Shoptaw
Journal:  Gend Med       Date:  2012-03-23

5.  Psychiatric symptoms and HPA axis function in adolescent methamphetamine users.

Authors:  George King; Daniel Alicata; Christine Cloak; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-01       Impact factor: 4.147

6.  Neonatal +-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists.

Authors:  Devon L Graham; Robyn M Amos-Kroohs; Amanda A Braun; Curtis E Grace; Tori L Schaefer; Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Int J Neuropsychopharmacol       Date:  2012-03-06       Impact factor: 5.176

7.  Effects of inhibiting neonatal methamphetamine-induced corticosterone release in rats by adrenal autotransplantation on later learning, memory, and plasma corticosterone levels.

Authors:  Curtis E Grace; Tori L Schaefer; Devon L Graham; Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Int J Dev Neurosci       Date:  2010-02-23       Impact factor: 2.457

8.  Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.

Authors:  Anantha Ram Nookala; Daniel C Schwartz; Nitish S Chaudhari; Alexy Glazyrin; Edward B Stephens; Nancy E J Berman; Anil Kumar
Journal:  Brain Behav Immun       Date:  2018-05-02       Impact factor: 7.217

9.  Neonatal exposure to amphetamine alters social affiliation and central dopamine activity in adult male prairie voles.

Authors:  D F Fukushiro; A Olivera; Y Liu; Z Wang
Journal:  Neuroscience       Date:  2015-08-28       Impact factor: 3.590

10.  Developmental methamphetamine exposure results in short- and long-term alterations in hypothalamic-pituitary-adrenal-axis-associated proteins.

Authors:  Damian G Zuloaga; Jessica A Siegel; Summer F Acevedo; Maayan Agam; Jacob Raber
Journal:  Dev Neurosci       Date:  2013-07-11       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.